Exploratory Study to Investigate Cognition Function and Mobility in Individuals With Pain

PHASE4TerminatedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

February 6, 2017

Study Completion Date

February 6, 2017

Conditions

Pain

Interventions

DRUG

Paracetamol and caffeine

Test product containing 500 mg paracetamol and 65 mg caffeine

DRUG

Paracetamol

Test product containing 500 mg paracetamol

OTHER

Placebo

Placebo to match paracetamol 665mg sustained release tablets

Trial Locations (1)

GSK Investigational Site, Brentford